It has been reported that LIPT1 is upregulated in melanoma and is an independent favorable prognostic indicator.[13] Therefore, LIPT1 may play a similar role in inhibiting tumor progression in NSCLC. Here, LIPT1 is linked to non-small cell lung carcinoma.